Karas RH - Search Results

1

Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.

Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Alsheikh-Ali AA, et al. Among authors: karas rh. Am J Cardiol. 2006 Nov 1;98(9):1231-3. doi: 10.1016/j.amjcard.2006.05.057. Epub 2006 Sep 7. Am J Cardiol. 2006. PMID: 17056335

2

A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression.

Kuvin JT, Rämet ME, Patel AR, Pandian NG, Mendelsohn ME, Karas RH. Kuvin JT, et al. Among authors: karas rh. Am Heart J. 2002 Jul;144(1):165-72. doi: 10.1067/mhj.2002.123145. Am Heart J. 2002. PMID: 12094204

3

The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers.

Kuvin JT, Karas RH. Kuvin JT, et al. Among authors: karas rh. Curr Opin Cardiol. 2003 Jul;18(4):295-300. doi: 10.1097/00001573-200307000-00009. Curr Opin Cardiol. 2003. PMID: 12858128 Review.

4

Relation between high-density lipoprotein cholesterol and peripheral vasomotor function.

Kuvin JT, Patel AR, Sidhu M, Rand WM, Sliney KA, Pandian NG, Karas RH. Kuvin JT, et al. Among authors: karas rh. Am J Cardiol. 2003 Aug 1;92(3):275-9. doi: 10.1016/s0002-9149(03)00623-4. Am J Cardiol. 2003. PMID: 12888130 Clinical Trial.

5

High-density lipoprotein cholesterol and coronary heart disease.

Young CE, Karas RH, Kuvin JT. Young CE, et al. Among authors: karas rh. Cardiol Rev. 2004 Mar-Apr;12(2):107-19. doi: 10.1097/01.crd.0000097140.29929.8a. Cardiol Rev. 2004. PMID: 14766026 Review.

6

Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.

Alsheikh-Ali AA, Karas RH. Alsheikh-Ali AA, et al. Among authors: karas rh. Am J Cardiol. 2004 Jun 1;93(11):1417-8, A9. doi: 10.1016/j.amjcard.2004.02.045. Am J Cardiol. 2004. PMID: 15165929

7

Risk of adverse events with fibrates.

Alsheikh-Ali AA, Kuvin JT, Karas RH. Alsheikh-Ali AA, et al. Among authors: karas rh. Am J Cardiol. 2004 Oct 1;94(7):935-8. doi: 10.1016/j.amjcard.2004.06.033. Am J Cardiol. 2004. PMID: 15464682

8

Comparison of flow-mediated dilatation of the brachial artery in coronary patients with low-density lipoprotein cholesterol levels <80 mg/dl versus patients with levels 80 to 100 mg/dl.

Kuvin JT, Patel AR, Sliney KA, Pandian NG, Karas RH. Kuvin JT, et al. Among authors: karas rh. Am J Cardiol. 2005 Jan 1;95(1):93-5. doi: 10.1016/j.amjcard.2004.08.067. Am J Cardiol. 2005. PMID: 15619399

9

Adverse events with concomitant amiodarone and statin therapy.

Alsheikh-Ali AA, Karas RH. Alsheikh-Ali AA, et al. Among authors: karas rh. Prev Cardiol. 2005 Spring;8(2):95-7. doi: 10.1111/j.1520-037x.2005.4060.x. Prev Cardiol. 2005. PMID: 15860984 Free article.

10

High-density lipoprotein cholesterol in the cardiovascular equation: does the "good" still count?

Alsheikh-Ali AA, Kuvin JT, Karas RH. Alsheikh-Ali AA, et al. Among authors: karas rh. Atherosclerosis. 2005 Jun;180(2):217-23. doi: 10.1016/j.atherosclerosis.2005.01.003. Atherosclerosis. 2005. PMID: 15910846 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters